ROCKVILLE, MD, April 19, 2016 — Therabron Therapeutics, Inc., a clinical-stage biotechnology company dedicated to advancing a new standard in respiratory care, today announced that Dr. Thomas F. Miller, President and Chief Executive Officer, will present at the World Orphan Drug Congress USA 2016, to be held April 21-22 at the Washington Hilton in Washington, D.C.

Read more here…